Enhanced Vascular Endothelial Growth Factor and Inflammatory Cytokine Removal With Online Hemodiafiltration Over High-Flux Hemodialysis in Sepsis-Related Acute Kidney Injury Patients

Therapeutic Apheresis and Dialysis

Volumn 17, Issue 5, 2013, Pages 557-563

  Chancharoenthana, Wiwat ^a   Tiranathanagul, Khajohn ^a   Srisawat, Nattachai ^a   Susantitaphong, Paweena ^a   Leelahavanichkul, Asada ^a   Praditpornsilpa, Kearkiat ^a   Tungsanga, Kriang ^a   Eiam Ong, Somchai ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Acute kidney injury; Cytokines; High flux hemodialysis; Online hemodiafiltration; Vascular endothelial growth factor

Indexed keywords

CYTOKINE; INOTROPIC AGENT; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BLEEDING; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ELECTROLYTE DISTURBANCE; FEMALE; HEMODIAFILTRATION; HEMODIALYSIS PATIENT; HEMODYNAMIC PARAMETERS; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HYPERTENSION; LENGTH OF STAY; MALE; ONLINE ANALYSIS; OUTCOME ASSESSMENT; PLASMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SEPSIS; SOLUTE; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ACUTE KIDNEY INJURY; CYTOKINES; HIGH-FLUX HEMODIALYSIS; ONLINE HEMODIAFILTRATION; VASCULAR ENDOTHELIAL GROWTH FACTOR;

ACUTE KIDNEY INJURY; ADULT; AGED; CYTOKINES; FEMALE; HEMODIAFILTRATION; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; SEPSIS; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84885851402     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/1744-9987.12016     Document Type: Article

References (23)

1. Palevsky PM, Zhang JH, O'Connor TZ etal. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008;359:7-20.
2. Bellomo R, Cass A, Cole L etal. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009;361:1627-1638.
3. Uchino S, Kellum JA, Bellomo R etal. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005;294:813-818.
4. Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med 2004;351:159-169.
5. Hirasawa H. Indications for blood purification in critical care. Contrib Nephrol 2010;166:21-30.
6. Murugan R, Karajala-Subramanyam V, Lee M etal. Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival. Kidney Int 2010;77:527-535.
7. van der Flier M, van Leeuwen HJ, van Kessel KP etal. Plasma vascular endothelial growth factor in severe sepsis. Shock 2005;23:35-38.
8. Pickkers P, Sprong T, Eijk L etal. Vascular endothelial growth factor is increased during the first 48 hours of human septic shock and correlates with vascular permeability. Shock 2005;24:508-512.
9. Yano K, Liaw PC, Mullington JM etal. Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med 2006;203:1447-1458.
10. Shapiro NI, Yano K, Okada H etal. A prospective, observational study of soluble FLT-1 and vascular endothelial growth factor in sepsis. Shock 2008;29:452-457.
11. Ebihara I, Hirayama K, Kaneko S etal. Vascular endothelial growth factor and soluble fms-like tyrosine kinase-1 in septic shock patients treated with direct hemoperfusion with a polymyxin B-immobilized fiber column. Ther Apher Dial 2008;12:285-291.
12. Blankestijn PJ, Ledebo I, Canaud B. Hemodiafiltration: clinical evidence and remaining questions. Kidney Int 2010;77:581-587.
13. Pettila V, Tiula E. Intermittent hemodiafiltration in acute renal failure in critically ill patients. Clin Nephrol 2001;56:324-331.
14. Vitale C, Bagnis C, Marangella M etal. Cost analysis of blood purification in intensive care units: continuous versus intermittent hemodiafiltration. J Nephrol 2003;16:572-579.
15. Saito A. Current progress in blood purification methods used in critical care medicine. Contrib Nephrol 2010;166:100-111.
16. Levy MM, Fink MP, Marshall JC etal. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250-1256.
17. Mehta RL, Kellum JA, Shah SV etal. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11:R31.
18. Feltes CM, Van Eyk J, Rabb H. Distant-organ changes after acute kidney injury. Nephron Physiol 2008;109:80-84.
19. Ward RA, Schmidt B, Hullin J etal. A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study. J Am Soc Nephrol 2000;11:2344-2350.
20. Maduell F, del Pozo C, Garcia H etal. Change from conventional haemodiafiltration to on-line haemodiafiltration. Nephrol Dial Transplant 1999;14:1202-1207.
21. Tiranathanagul K, Yossundharakul C, Techawathanawanna N etal. Comparison of middle-molecule clearance between convective control double high-flux hemodiafiltration and on-line hemodiafiltration. Int J Artif Organs 2007;30:1090-1097.
22. Panich A, Tiranathanagul K, Praditpornsilpa K etal. The effectiveness of on-line hemodiafiltration on beta-2 microglobulin clearance in end-stage renal disease. J Med Assoc Thai 2006;89(Suppl 2):S1-8.
23. Ronco C, Bonello M, Bordoni V etal. Extracorporeal therapies in non-renal disease: treatment of sepsis and the peak concentration hypothesis. Blood Purif 2004;22:164-174.